Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Secretin 3Everolimus 2Sirolimus 1Magnetic Resonance Spectroscopy 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Data Collection 1Celecoxib 1CA-19-9 Antigen 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peutz-Jeghers Syndrome × Celecoxib × Clear all
NCT06722534 2025-05-30

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome

Air Force Military Medical University, China

Phase NA Recruiting
80 enrolled

Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡